When compared to prescribed antidepressants, psychedelics may be a better treatment for cancer patients' symptoms of anxiety and depression.

Published Date: 26 Apr 2023

Psilocybin, LSD, and MDMA are psychedelic drugs that may significantly lessen the severity of depression and anxiety symptoms in people with advanced cancer.

Read Full News

Latest News



Todays Updates


Novel imaging approach may improve treatment for spinal cord injuries


Northwestern Medicine investigators have developed a new imaging approach to more accurately assess blood flow in the spinal cord, a method that could be used to better inform treatment for neurological diseases and injuries, ...

Parents of neurodivergent kids need support. But those who need it most often wait longer


Parenting any young child is full of highs and lows. In addition to these, parents and caregivers of children with neurodevelopmental conditions such as autism and attention-deficit hyperactivity disorder (ADHD) are more ...

Study shows over 90% of older adults with dementia undergo burdensome interventions in their final year


A new study by researchers from Duke-NUS Medical School has revealed that almost all community-dwelling older adults with advanced dementia in Singapore experience at least one potentially burdensome intervention in their ...

What polymers can teach us about curing Alzheimer's disease


Researchers from Tokyo Metropolitan University have applied ideas from polymer physics to illuminate the mechanism behind a key pathology in Alzheimer's disease, the formation of fibrils of tau proteins. They showed that ...

Mild cognitive impairment, dementia risk up with increasing biological severity of Alzheimer's disease


For individuals who are currently cognitively unimpaired, the lifetime and 10-year absolute risk of mild cognitive impairment (MCI) and dementia increases with increasing amyloid positron emission tomography (PET) centiloid ...

Gene 'switch' reverses Alzheimer's risk in experimental model


University of Kentucky researchers have developed a new experimental model that could point the way toward more effective Alzheimer's disease treatments by targeting one of the brain's most important genes for risk and resilience.

Unregulated and unsafe: Expert warns of risks in substance use reduction apps


In a commentary published by the Journal of the American Medical Association, researchers at Rutgers Health, Harvard University and the University of Pittsburgh discuss the impact of unregulated mobile health and generative ...

Todays Updates


Novel imaging approach may improve treatment for spinal cord injuries


Northwestern Medicine investigators have developed a new imaging approach to more accurately assess blood flow in the spinal cord, a method that could be used to better inform treatment for neurological diseases and injuries, ...

Parents of neurodivergent kids need support. But those who need it most often wait longer


Parenting any young child is full of highs and lows. In addition to these, parents and caregivers of children with neurodevelopmental conditions such as autism and attention-deficit hyperactivity disorder (ADHD) are more ...

Study shows over 90% of older adults with dementia undergo burdensome interventions in their final year


A new study by researchers from Duke-NUS Medical School has revealed that almost all community-dwelling older adults with advanced dementia in Singapore experience at least one potentially burdensome intervention in their ...

What polymers can teach us about curing Alzheimer's disease


Researchers from Tokyo Metropolitan University have applied ideas from polymer physics to illuminate the mechanism behind a key pathology in Alzheimer's disease, the formation of fibrils of tau proteins. They showed that ...

Mild cognitive impairment, dementia risk up with increasing biological severity of Alzheimer's disease


For individuals who are currently cognitively unimpaired, the lifetime and 10-year absolute risk of mild cognitive impairment (MCI) and dementia increases with increasing amyloid positron emission tomography (PET) centiloid ...

Gene 'switch' reverses Alzheimer's risk in experimental model


University of Kentucky researchers have developed a new experimental model that could point the way toward more effective Alzheimer's disease treatments by targeting one of the brain's most important genes for risk and resilience.

Unregulated and unsafe: Expert warns of risks in substance use reduction apps


In a commentary published by the Journal of the American Medical Association, researchers at Rutgers Health, Harvard University and the University of Pittsburgh discuss the impact of unregulated mobile health and generative ...

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Scholastic performance is a key concern for young cancer patients, study finds

2.

Colorectal Cancer Screening Uptake Tripled in 45-49 Age Group

3.

Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC

4.

CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma

5.

Firefighters who eat better can combat cancer.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot